SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — John Henry Holliday Synthetic CCD — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientJohn Henry Holliday
Date of birth1851-08-14
IdentifiersMRN HR-NI007-SYN-TD; SSN (made up) 000-07-8153
Document date2026-11-01
AuthorMartin Beaumont, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

Diagnosis of cavitary pulmonary tuberculosis: sputum, chest X-ray, baseline tests, public-health report, home isolation, and alcohol assessment with a safety assessment. Concerns: He wants to get back to his dental practice as soon as it is safe for his patients; He is frightened by the diagnosis and wants to know that it can be cured. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Isoniazid 300 mg tablet, one tablet daily300 mg once daily by video-observed therapy with the health department, seven days a week, for six monthsOral route1873-02-12 to 1873-08-13completedS
Rifampin 300 mg capsules, two capsules (600 mg) daily600 mg once daily on an empty stomach by video-observed therapy with the health department, seven days a week, for six monthsOral route1873-02-12 to 1873-08-13completedS
Pyrazinamide 500 mg tablets, three tablets (1500 mg) daily1500 mg once daily by video-observed therapy with the health department, seven days a week, for the eight-week intensive phaseOral route1873-02-12 to 1873-04-08completedS
Ethambutol 400 mg tablets, three tablets (1200 mg) daily1200 mg once daily by video-observed therapy with the health department, seven days a week, until susceptibility results returnOral route1873-02-12 to 1873-03-10stoppedS
Vitamin B6 (pyridoxine) 50 mg tablet, one tablet daily50 mg once daily with isoniazidOral route1873-02-12 to 1873-08-13completedS

Procedures

ProcedureDatesStatusEvidence
Chest X-ray, two views: right upper lobe consolidation with a 3 cm thick-walled cavity; no effusion or hilar enlargement1873-02-10 to 1873-02-10completedS
Chest X-ray, two views, at the end of treatment: cavity closed, with residual right upper lobe scarring; kept as the baseline for any future comparison1873-08-18 to 1873-08-18completedS

Immunizations

DateVaccineStatusEvidence
1869-08-30Tetanus, diphtheria, and pertussis (Tdap) boostercompletedS
1873-09-22Influenza vaccine, 1873-1874 seasoncompletedS
1873-09-22Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1872Developed a bad cough shortly after beginning to practice dentistryD (CLM-0004)

Family History

RelativeConditionAge at deathEvidence
motherPulmonary tuberculosis; died of it in 1866D (CLM-0002)

Health Concerns

ConcernStatusEvidence
He wants to get back to his dental practice as soon as it is safe for his patientsactiveS
He is frightened by the diagnosis and wants to know that it can be curedactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 14.4 on 1873-08-18; Leukocytes [#/volume] in Blood by Automated count 9.4 on 1873-02-10; Platelets [#/volume] in Blood by Automated count 412 on 1873-02-10; Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 64 on 1873-05-19; Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 58 on 1873-05-19; Bilirubin.total [Mass/volume] in Serum or Plasma 0.9 on 1873-05-19; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 98 on 1873-05-19; Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma 78 on 1873-02-10; Albumin [Mass/volume] in Serum or Plasma 3.4 on 1873-02-10; Creatinine [Mass/volume] in Serum or Plasma 0.86 on 1873-02-10; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1868)/1.73 sq M 124 on 1873-02-10; Glucose [Mass/volume] in Serum or Plasma 90 on 1873-02-10; Hemoglobin A1c/Hemoglobin.total in Blood 5.2 on 1873-02-10; Visual acuity uncorrected Right eye by ETDRS eye chart 85 on 1873-02-24; Visual acuity uncorrected Left eye by ETDRS eye chart 84 on 1873-02-24; Total score [AUDIT] 15 on 1873-02-10; Total score [AUDIT-C] 3 on 1873-09-22; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 on 1873-08-18; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 1873-09-22 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Pulmonary tuberculosis, right upper lobe cavitary, sputum smear-positive, confirmed by nucleic acid amplification without rifampin resistanceactiveconfirmed A15.0S — Synthetic modern coding of his documented pulmonary tuberculosis at the time of diagnosis; the bacteriology is synthetic.
Alcohol use disorder, mild, with binge drinkingactiveconfirmed F10.10S — Synthetic modern coding anchored to the documented heavy drinking; the severity and the criteria met are synthetic.
Acute viral gastroenteritis during tuberculosis treatment, with a mild aminotransferase rise below the threshold for drug-induced liver injury; resolvedresolvedconfirmed A08.4S — Synthetic intercurrent illness chosen to teach the assessment of nausea on isoniazid and rifampin; it does not echo a documented illness.

Results

DateMeasureValueUnitReference rangeFlagProvenance
1873-02-10Hemoglobin [Mass/volume] in Blood12.6g/dL13.2-16.6 g/dLLowS
1873-02-10Leukocytes [#/volume] in Blood by Automated count9.410*3/uL4-11 10*3/uLNormalS
1873-02-10Platelets [#/volume] in Blood by Automated count41210*3/uL150-400 10*3/uLHighS
1873-02-10Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma34U/L7-56 U/LNormalS
1873-02-10Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L10-40 U/LNormalS
1873-02-10Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
1873-02-10Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma92U/L40-129 U/LNormalS
1873-02-10Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma78U/L8-61 U/LHighS
1873-02-10Albumin [Mass/volume] in Serum or Plasma3.4g/dL3.5-5 g/dLLowS
1873-02-10Creatinine [Mass/volume] in Serum or Plasma0.86mg/dL0.74-1.35 mg/dLNormalS
1873-02-10Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1868)/1.73 sq M124mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1873-02-10Glucose [Mass/volume] in Serum or Plasma90mg/dL70-99 mg/dLNormalS
1873-02-10Hemoglobin A1c/Hemoglobin.total in Blood5.2%<=5.6%NormalS
1873-02-10Visual acuity uncorrected Right eye by ETDRS eye chart85{letters}>=80NormalS
1873-02-10Visual acuity uncorrected Left eye by ETDRS eye chart85{letters}>=80NormalS
1873-02-10Total score [AUDIT]15{score}S
1873-02-10Total score [AUDIT-C]9{score}S
1873-02-10Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]6{score}S
1873-02-24Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma41U/L7-56 U/LNormalS
1873-02-24Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma39U/L10-40 U/LNormalS
1873-02-24Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
1873-02-24Visual acuity uncorrected Right eye by ETDRS eye chart85{letters}>=80NormalS
1873-02-24Visual acuity uncorrected Left eye by ETDRS eye chart84{letters}>=80NormalS
1873-02-24Total score [AUDIT-C]4{score}S
1873-03-17Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma52U/L7-56 U/LNormalS
1873-03-17Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma47U/L10-40 U/LHighS
1873-03-17Bilirubin.total [Mass/volume] in Serum or Plasma0.8mg/dL0.1-1.2 mg/dLNormalS
1873-03-17Total score [AUDIT-C]2{score}S
1873-04-14Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma38U/L7-56 U/LNormalS
1873-04-14Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma35U/L10-40 U/LNormalS
1873-04-14Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
1873-04-14Total score [AUDIT-C]1{score}S
1873-08-18Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma30U/L7-56 U/LNormalS
1873-08-18Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma28U/L10-40 U/LNormalS
1873-08-18Bilirubin.total [Mass/volume] in Serum or Plasma0.6mg/dL0.1-1.2 mg/dLNormalS
1873-08-18Hemoglobin [Mass/volume] in Blood14.4g/dL13.2-16.6 g/dLNormalS
1873-08-18Total score [AUDIT-C]3{score}S
1873-08-18Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]3{score}S
1873-05-19Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma64U/L7-56 U/LHighS
1873-05-19Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma58U/L10-40 U/LHighS
1873-05-19Bilirubin.total [Mass/volume] in Serum or Plasma0.9mg/dL0.1-1.2 mg/dLNormalS
1873-05-19Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma98U/L40-129 U/LNormalS
1873-05-19Total score [AUDIT-C]4{score}S
1873-09-22Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S
1873-09-22Total score [AUDIT-C]3{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
1873-02-10Body height178cmS
1873-02-10Body weight58kgS
1873-02-10Body mass index (BMI) [Ratio]18.3kg/m2S
1873-02-10Systolic blood pressure112mm[Hg]S
1873-02-10Diastolic blood pressure70mm[Hg]S
1873-02-10Heart rate104/minS
1873-02-10Respiratory rate20/minS
1873-02-10Body temperature37.8CelS
1873-02-10Oxygen saturation in Arterial blood by Pulse oximetry95%S
1873-02-24Body height178cmS
1873-02-24Body weight59kgS
1873-02-24Body mass index (BMI) [Ratio]18.6kg/m2S
1873-02-24Systolic blood pressure114mm[Hg]S
1873-02-24Diastolic blood pressure72mm[Hg]S
1873-02-24Heart rate92/minS
1873-02-24Respiratory rate18/minS
1873-02-24Body temperature37.3CelS
1873-02-24Oxygen saturation in Arterial blood by Pulse oximetry96%S
1873-03-17Body height178cmS
1873-03-17Body weight61kgS
1873-03-17Body mass index (BMI) [Ratio]19.3kg/m2S
1873-03-17Systolic blood pressure116mm[Hg]S
1873-03-17Diastolic blood pressure72mm[Hg]S
1873-03-17Heart rate84/minS
1873-03-17Respiratory rate16/minS
1873-03-17Body temperature36.8CelS
1873-03-17Oxygen saturation in Arterial blood by Pulse oximetry97%S
1873-04-14Body height178cmS
1873-04-14Body weight62.5kgS
1873-04-14Body mass index (BMI) [Ratio]19.7kg/m2S
1873-04-14Systolic blood pressure116mm[Hg]S
1873-04-14Diastolic blood pressure74mm[Hg]S
1873-04-14Heart rate78/minS
1873-04-14Respiratory rate16/minS
1873-04-14Body temperature36.7CelS
1873-04-14Oxygen saturation in Arterial blood by Pulse oximetry98%S
1873-08-18Body height178cmS
1873-08-18Body weight65.5kgS
1873-08-18Body mass index (BMI) [Ratio]20.7kg/m2S
1873-08-18Systolic blood pressure118mm[Hg]S
1873-08-18Diastolic blood pressure74mm[Hg]S
1873-08-18Heart rate72/minS
1873-08-18Respiratory rate14/minS
1873-08-18Body temperature36.6CelS
1873-08-18Oxygen saturation in Arterial blood by Pulse oximetry98%S
1873-05-19Body height178cmS
1873-05-19Body weight61.8kgS
1873-05-19Body mass index (BMI) [Ratio]19.5kg/m2S
1873-05-19Systolic blood pressure108mm[Hg]S
1873-05-19Diastolic blood pressure68mm[Hg]S
1873-05-19Heart rate98/minS
1873-05-19Respiratory rate16/minS
1873-05-19Body temperature37.4CelS
1873-05-19Oxygen saturation in Arterial blood by Pulse oximetry98%S
1873-09-22Body height178cmS
1873-09-22Body weight66kgS
1873-09-22Body mass index (BMI) [Ratio]20.8kg/m2S
1873-09-22Systolic blood pressure118mm[Hg]S
1873-09-22Diastolic blood pressure72mm[Hg]S
1873-09-22Heart rate68/minS
1873-09-22Respiratory rate14/minS
1873-09-22Body temperature36.6CelS
1873-09-22Oxygen saturation in Arterial blood by Pulse oximetry98%S

Encounters

DatePurposeStatusProvenance
1873-02-10Diagnosis of cavitary pulmonary tuberculosis: sputum, chest X-ray, baseline tests, public-health report, home isolation, and alcohol assessment with a safety assessmentfinishedS
1873-02-24Two-week follow-up on treatment with infectious diseases consultationfinishedS
1873-03-17Five-week review: susceptibility results, release from isolation, and liver monitoringfinishedS
1873-04-14End of the intensive phase: two-month sputum and the start of the continuation phasefinishedS
1873-08-18End-of-treatment review after six monthsfinishedS
1873-05-19Same-day sick visit for nausea and vomiting during tuberculosis treatmentfinishedS
1873-09-22Adult preventive visitfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Infectious diseases consultation to confirm the regimen and plan monitoring for cavitary pulmonary tuberculosis in a man who drinks heavilycompletedGL-ATS-TB-2016, GL-ATS-TB-2025S
Standard treatment: isoniazid, rifampin, pyrazinamide, and ethambutol for eight weeks, then isoniazid and rifampin for eighteen weeks, by video-observed therapy with the health department, with pyridoxinecompletedGL-ATS-TB-2016S
Monitoring: monthly symptom and weight check, sputum smear and culture monthly until two consecutive cultures are negative, liver tests at two weeks and monthly because of alcohol, and vision checks while on ethambutolcompletedGL-ATS-TB-2016, GL-ATS-HEPATOTOX-2006S
Public health: same-day report to the local health department, home isolation until noninfectious, and a contact investigation of his household, coworkers, and patients led by the health departmentcompletedGL-CDC-CONTACT-2005, GL-ATS-TB-2016S
Alcohol care: brief intervention at diagnosis, a goal of no alcohol during treatment, counseling with a substance-use counselor, medication offered, AUDIT-C at each visit, and a safety review with the 988 Suicide & Crisis Lifeline at every visitcompletedGL-USPSTF-ALC-2018, GL-SUD-2021, GL-SUICIDE-2024S

Goals

GoalTargetStatusOutcomeProvenance
Complete 182 doses of treatment under video-observed therapy within six months1873-08-18completedAll 182 doses completed: 56 in the intensive phase and 126 in the continuation phase, with one dose held during a stomach illness and made up at the endS
Sputum culture negative at two months1873-08-18completedTwo-month culture showed no growth, so the continuation phase stayed at four monthsS
No alcohol during treatment, to protect his liver1873-08-18activeNot fully met: no drinking for most of the six months, with one evening of heavy drinking at a party about three months into treatment; AUDIT-C 3 at the endS
Return to work once he is no longer infectious1873-03-17completedReleased from home isolation after three negative sputum smears and back at work four weeks into treatmentS
Weight back to at least 64 kg by the end of treatment1873-08-18completed65.5 kg at the end of treatment, from 58.0 kg at diagnosisS

Functional Status

Mental Status

Structured synthetic safety assessment on 1873-02-10: current ideation absent, intent absent, plan absent. Routine outpatient care. A new serious diagnosis, isolation, and heavy drinking can raise suicide risk, so safety is reviewed at every visit. He saved the 988 Suicide & Crisis Lifeline in his phone. No firearm in the home [S]